Toronto, Ontario--(Newsfile Corp. - January 7, 2015) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm Solutions" or the "Company") today announced that it
has granted 250,000 incentive stock options to Etienne Grima, the Company's CEO,
in accordance with Mr. Grima's employment agreement. The options are exercisable
at $0.055 per share for five years from the date of grant, vest four months from
the date of grant and are subject to a four month hold period. The grant of
options is subject to the provisions of the Company's Stock Option Plan, the
policies of the TSX Venture Exchange and applicable securities laws.
About CardioComm Solutions
CardioComm Solutions' patented and proprietary technology is
used in products for recording, viewing, analyzing and storing
electrocardiograms (ECGs) for diagnosis and management of cardiac patients.
Products are sold worldwide through a combination of an external distribution
network and a North American-based sales team. The Company has earned the ISO
13485 certification, is HPB approved, HIPAA compliant, and has received FDA
market clearance for its software devices. CardioComm Solutions is headquartered
in Toronto, Ontario, Canada, with offices in Victoria, B.C.
FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief
Executive Officer
1-877-977-9425 x 227
investorrelations@cardiocommsolutions.com
www.cardiocommsolutions.com
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
copyright (c) newsfile corp. 2015. all rights reserved